Lynn Rapsilber
Adult Health · Torrington, CTNPI 1669465829
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $31,520 of the $51,567 with a category attached, or 61.1%. Gilead accounts for 97.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $15,712 and has fallen 77.4% since, to $3,556 in 2025. Among adult health clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $284.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$50K
- AbbVie$286
- Ferring Pharmaceuticals Inc.$177
- Bristol Myers Squibb$157
- Nestle Healthcare Nutrition Inc.$151
- Johnson & Johnson$147
- plus $543 from 8 others
What the payments were for
- Consulting fees$900%
- Speaking & faculty fees$31,52061%
- Travel & lodging$16,09031%
- Food & beverage$3,8677%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 117 | $50,107 |
| AbbVie | 19 | $286 |
| Ferring Pharmaceuticals Inc. | 4 | $177 |
| Bristol Myers Squibb | 6 | $157 |
| Nestle Healthcare Nutrition Inc. | 8 | $151 |
| Johnson & Johnson | 7 | $147 |
| Bayer | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $119 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $104 |
| Sanofi | 2 | $56 |
| Intercept Pharmaceuticals, Inc. | 3 | $51 |
| Ironwood Pharmaceuticals, Inc | 2 | $46 |
| Braintree Laboratories, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$51,567 in reported general payments places this provider in the 95th percentile of 418 adult health providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 12 | $42,976 |
| LinzessLinaclotide | 50 | $33,648 |
| Dexlansoprazole DrDexlansoprazole | 19 | $10,773 |
| Lansoprazole | 23 | $1,277 |
| Pantoprazole Sodium | 96 | $1,182 |
| Omeprazole | 40 | $679 |
| Famotidine | 35 | $368 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $286 | $76,62462 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 418 adult health providers in Connecticut.
Other adult health in Torrington
- Lauren OzimekTorrington$5K
- Janeen WhiteTorrington$4K
- Leah EhleManchester$418K
- Laura MulkaWethersfield$306K
- Gretchen MichaelsonSouth Windsor$169K
- Kimberly RyanWethersfield$74K
- Kathryn JackMeriden$67K
- Genice NelsonFarmington$36K
- Andrea LauterNew London$32K
- Megan CarlucciManchester$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.